文献速递胸部肿瘤放疗放疗物理与技术

多发性肺转移瘤单中心SBRT的边界计算

Margin calculation for multiple lung metastases treated with single-isocenter SBRT.
PubMed 文献 · Radiother Oncol · 2021-07-10

该研究基于42例NSCLC患者的83对肺转移瘤,通过计划CT与验证CBCT的病灶配准量化病灶间位置变异,并计算单中心肺SBRT的安全边界。结果显示病灶间位置变异平均为1.2±1.1 mm(3D矢量),在纳入该变异后全队列安全边界从5.6、5.8、5.2 mm(AP、SI、LR)增至6.0、6.6、5.5 mm。结论认为相对病灶间位置变异受靶区间距离和位置影响,可通过<1 mm的额外安全边界补偿。

要点

  • 病灶间位置变异平均1.2±1.1 mm,≥1个病灶未贴胸膜或病灶距离远时显著增加。
  • 纳入病灶间变异后,全队列AP、SI、LR边界分别增至6.0、6.6、5.5 mm。
  • 单中心SBRT可通过<1 mm额外安全边界补偿病灶间位置变异。

核心结论

  • 相对病灶间位置变异受靶区间距离和位置影响,单中心SBRT可通过<1 mm的额外安全边界进行补偿。

研究设计与样本

  • 回顾性分析42例NSCLC患者的83对肺转移瘤,基于计划CT与验证CBCT进行病灶配准计算相对病灶间位置变异。
  • 通过模拟球形病灶评估van Herk边界公式中β值在非均匀计划剂量分布下的适用性。
  • 使用全数据集及相对病灶间位置变异存在显著差异的亚组计算基于人群的ITV至PTV边界。

主要发现

  • 病灶间位置变异以3D矢量计平均±SD为1.2±1.1 mm。
  • 若≥1个病灶未贴胸膜或病灶距离远,病灶间位置变异显著增加。
  • 模拟显示在65%剂量处方下,随机误差的合并SD仅在SI方向以0.25∙σtot贡献于边界。
  • 纳入病灶间位置变异后,全队列安全边界从5.6、5.8、5.2 mm(AP、SI、LR)增至6.0、6.6、5.5 mm。

关键数值与推荐

  • 全队列ITV至PTV边界(纳入病灶间位置变异):AP 6.0 mm、SI 6.6 mm、LR 5.5 mm。
  • 未纳入病灶间位置变异时全队列边界:AP 5.6 mm、SI 5.8 mm、LR 5.2 mm。
  • 病灶间位置变异平均3D矢量为1.2±1.1 mm。

临床怎么用

  • 单中心肺SBRT制定ITV至PTV边界时应考虑病灶间位置变异,尤其当病灶未贴胸膜或靶区间距离较远时。
  • 可参考本研究全队列边界值(AP 6.0 mm、SI 6.6 mm、LR 5.5 mm)并结合本中心数据调整。
  • 对病灶间位置变异较大的病例,需增加<1 mm的额外安全边界以补偿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: A single-isocenter stereotactic body radiotherapy (SBRT) approach for multiple lung metastases has the potential to lower cumulative patient dose and reduce overall treatment time. However, the magnitude of inter-lesion position variation is currently unknown and not incorporated in margin calculations. The aim of this study was to quantify inter-lesion position variation and calculate safety margins for single-isocenter lung SBRT. MATERIALS AND METHODS: A total of 83 pairs of pulmonary metastases from 42 NSCLC patients were used to calculate relative inter-lesion position variation by lesion-based registration of planning CT and verification CBCT. Furthermore, β-value assessment of van Herk's margin formula was performed by evaluating the distance between planned and blurred dose profiles of simulated spherical lesions, to evaluate its validity for heterogeneously planned dose distributions. Population-based ITV to PTV margins were calculated using the entire dataset and using subgroups with significant differences in relative inter-lesion position variation. RESULTS: The mean ± SD inter-lesion position variation was 1.2 ± 1.1 mm as 3D-vector. Inter-lesion position variation was significantly increased if ≥1 lesion was not attached to the pleura or lesions were distant. The simulation showed that the combined SD of the random errors contributed to the margin only in the SI direction with 0.25∙σtot for a 65% dose prescription. When incorporating inter-lesion position variation, the safety margins increased from 5.6, 5.8, 5.2 mm (AP, SI, LR) to 6.0, 6.6, 5.5 mm for the entire cohort. CONCLUSION: Relative inter-lesion position variation is influenced by inter-target distance and location and can be compensated with additional safety margins of <1 mm using single-isocenter SBRT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. van Timmeren JE, Hoogeman MS, Ehrbar S, et al. Margin calculation for multiple lung metastases treated with single-isocenter SBRT. Radiother Oncol. 2021. PMID: 34252484. doi:10.1016/j.radonc.2021.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。